Hologic closes Fischer IP acquisition:
This article was originally published in Clinica
Bedford, Massachusetts-based digital imaging systems developer Hologic has completed its acquisition of intellectual property rights to Fischer Imaging's mammography business and products. Hologic paid $32m in total for the rights to Fischer's SenoScan digital mammography and MammoTest stereotactic breast biopsy systems. Around $27m of the purchase price was paid in cash and $5m was through the cancellation of an outstanding loan between the two companies. The acquisition is part of Hologic's drive to expand its market share in women's health and strengthen its position in the mammography market.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.